PLA2G4B antibody
Principal name
PLA2G4B antibody
Alternative names for PLA2G4B antibody
cPLA2-beta, phospholipase A2 beta, Cytosolic phospholipase A2 beta, Phospholipase A2 group IVB
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), ELISA (detection) (E(detection)), Immunocytochemistry/Immunofluorescence (ICC/IF), Paraffin Sections (P), Immunoprecipitation (IP)
Background of PLA2G4B antibody
PLA2G4B gene transcribes naturally-occurring mRNAs that are co-transcribed products of the neighboring JMJD7 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD).The LOC100137047-PLA2G4B mRNAs are naturally occurring co-transcribed products of the neighboring LOC100137047 and PLA2G4B genes. Incompletely processed read-through transcripts from these two loci are abundantly expressed in most tissues, but the function of the predicted protein product has not yet been determined. Alternative splicing of this gene results in different transcript variants, some of which are candidates for nonsense-mediated decay (NMD).
General readings
Ghosh,M., (2006) J. Biol. Chem. 281 (24), 16615-16624
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC223316L2V | Lenti ORF particles, JMJD7 (mGFP-tagged) - Human JMJD7-PLA2G4B readthrough (JMJD7-PLA2G4B), transcript variant 1, 200 uL, >10^7 TU/mL |
|
 |
200 µl /
€2,190.00
|
|
| OriGene Technologies, Inc. | ||
| RC231436L2V | Lenti ORF particles, JMJD7 (mGFP-tagged)-Human JMJD7-PLA2G4B readthrough (JMJD7-PLA2G4B), transcript variant 3, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,000.00
|
|
| OriGene Technologies, Inc. | ||